The Christie NHS Foundation Trust

The Christie NHS Foundation Trust Please note this account is only monitored 9am – 5pm Monday to Friday (not Bank Holidays). To cont These services help increase income for our NHS developments.

The Christie is one of Europe’s leading cancer centres, treating more than 44,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester and Cheshire, but as a national specialist around 26% patients are referred to us from other parts of the country. Our annual turnover is £173 million and we have 2,500 staff, 350 volunteers and 18,000 public members. NHS services
We provide:
• radiotherapy through one of the largest radiotherapy departments in the world, both on our main site in south Manchester and via The Christie radiotherapy centre in Oldham
• chemotherapy in the largest chemotherapy unit in the UK and via 14 other hospitals
• highly specialist surgery for complex and rare cancer
• a wide range of support and diagnostic services

Research & Education
We are also an international leader in research, with world first breakthroughs for over 100 years. Our clinical trials unit is the largest early phase trials unit in the world, with around 200 trials ongoing at any one time. We are part of the Manchester Cancer Research Centre with The University of Manchester and Cancer Research UK and also one of seven partners in the Manchester Academic Health Science Research Centre. Cancer research in Manchester has been officially ranked the best in the UK. The Christie School of Oncology provides undergraduate education, clinical professional and medical education and is the first of its kind in the UK. Joint ventures
We provide private patient services through The Christie Clinic, our joint venture with HCA International. Developments
Our developments are breaking new ground and transforming treatment and care for cancer patients. These include a unique network of Christie radiotherapy centres in other parts of the area to deliver treatment closer to people’s homes and the development of our young oncology services in partnership with the Teenage Cancer Trust. History
We have achieved world firsts since The Christie was established in 1901. It was named The Christie in recognition of the pioneering work of both Richard Copley Christie and his wife Mary Ellen Christie. At this time there were 30 beds and 463 patients a year. Charity
Our charity is the second largest hospital charity in the country. Over 2,000 fundraisers and 20,000 supporters help bring in £15.9 million a year, which helps fund additional patient services and vital research. To find ‘The Christie charity’ on facebook please follow this link

Today,  on World Cancer Day, the government has launched its National Cancer Plan for England.Designed in collaboration ...
04/02/2026

Today, on World Cancer Day, the government has launched its National Cancer Plan for England.

Designed in collaboration with patients and experts, it focuses on increasing earlier diagnosis, improving performance, improving quality of life, and reducing inequalities.

As one of three specialist cancer centres in England, The Christie plays a crucial role in delivering these ambitions for patients across Greater Manchester and beyond.

Dr Neil Bayman, Executive Medical Director at The Christie, has written a blog sharing his initial thoughts on key elements of the plan, including care closer to home, early diagnosis, and the use of cutting-edge technology.

"The publication of the National Cancer Plan reinforces the direction we are already taking," he says. "The key commitments, including more personalised support and more consistent access to care, align with our neighbourhood oncology plans and our long-standing commitment to delivering the highest quality care for our patients.

"Over the coming weeks, we will review the plan in full and consider what it means for our patients, our staff and our role within the wider system. Above all, our focus will remain on what matters most: delivering the best possible care for our patients, wherever they are and whatever their needs. "

Read the full blog. 👇

Ahead of World Cancer Day tomorrow (4 February), BBC Radio 5 live and BBC Newsround visited The Christie to learn more a...
03/02/2026

Ahead of World Cancer Day tomorrow (4 February), BBC Radio 5 live and BBC Newsround visited The Christie to learn more about the things we're doing to improve the lives of people with cancer.

We'll be on Newsround today and on the radio both today and tomorrow.

Today is all about Rama, a 10-year-old from Bradford who is having proton beam therapy, a type of radiotherapy.

She was the first patient to explore our proton beam therapy in Minecraft. It's believed to be the first time that a working NHS health facility has been accurately reconstructed within the game.

Our team hopes the new play environment will help to reduce the anxiety that young patients feel when they come for their first proton beam therapy treatment.

Rama certainly thinks it does.

“It looks just the same as the hospital, it’s so cool,” she says. “I got to explore the playroom and the gantry where I have treatment every day. The hospital feels very big when you get here, so being able to explore it in Minecraft helps you to understand where everything is, which is great. I think other children would love it just as much as I do.”

Listen in or read more on the BBC website. 👇

01/02/2026

Over 10,000 people have now signed up to our online portal, MyChristie. 🎉

Patients can check most upcoming appointments, view clinical letters, and update their care teams using health questionnaires.

Sign up in four easy steps:

1.) Go to christie.nhs.uk/mychristie and click 'sign up
2.) Enter your details
3.) You'll receive a password and code by email or text
4.) Use the password and code to log in

The patient portal is part of Future Christie, our 10-year transformation programme designed to make care more personal, joined-up and efficient, while keeping the same compassionate touch that The Christie is known for.

Meet Roxy Afzal. Roxy is an advanced nurse practitioner in our proton beam therapy unit. Roxy works as part of the team ...
30/01/2026

Meet Roxy Afzal. Roxy is an advanced nurse practitioner in our proton beam therapy unit. Roxy works as part of the team providing medical support to children receiving proton beam therapy, for example, helping to manage complicated or unexpected side-effects during treatment.

Roxy has been at The Christie for around two years now, having previously worked in public health and in neonatal health. Before she joined the NHS she’d had a varied career from marketing, to acting and working as cabin crew.

One of Roxy’s big passions is racial equality - from both a staff and a patient perspective. She is the engagement lead for our REACH staff network group (race, ethnicity, and cultural heritage). She believes its vital to celebrate diversity, and that people from different backgrounds improve the care we offer because of the lived experiences and knowledge they have of different cultures.

This coming week at The Christie (Monday 2 February - Friday 6 February) , we will be marking Racial Equality Week with a series of events including daily Lunch and Learn sessions via Teams (details available on HIVE for Christie staff) as well as awareness information and events at our engagement stand next to the restaurant. Come along and find out more.

Together,

Did you know that Christie radiographers delivered over 100,000 radiotherapy treatments last year?Join us on Saturday, 7...
28/01/2026

Did you know that Christie radiographers delivered over 100,000 radiotherapy treatments last year?

Join us on Saturday, 7 March, to find out more about radiotherapy careers here.

You’ll get to hear about everything from initial scanning and planning to treatment delivery, see all the machines, and chat to our brilliant team about their careers.

📆 Saturday, 7 March, 9am
📌 Proton beam therapy centre at The Christie in Withington.

“I love being a radiographer because I get to work directly with people, use some seriously cool tech, and be part of something that genuinely helps. Knowing that I make a difference to people is why I do what I do.” - Shaun

Link to register is in the comments. 👇

Sam Birchall, the lead guitarist in indie band The Lilacs, is the first person in Europe to have a lymph node removal op...
26/01/2026

Sam Birchall, the lead guitarist in indie band The Lilacs, is the first person in Europe to have a lymph node removal operation for testicular cancer that has spread and go home the same day.

Sam, who is from Wigan, was diagnosed last year when he was just 24. He had an operation at his local hospital to remove his testicle. Unfortunately, his scans revealed that the cancer had spread to some of his abdominal lymph nodes, so he had 3 cycles of chemotherapy at The Christie, which he finished in September last year.

After chemotherapy, further tests showed that some of the lymph nodes were still enlarged and that he needed an operation to remove them.

“My surgeon, Mr Aziz Gulamhusein, was very straight with me that my case was complicated, as some of the lymph nodes were pressing up against major blood vessels. It was scary, but I have always felt in very safe hands at The Christie, and this was no different.

“I had a robotic operation, which generally has a much shorter recovery time than open surgery, but I never expected to leave hospital the same day. The nurses were great in the recovery room, and by the time Aziz came to see me at the end of the day, I was feeling pretty good. It really couldn’t have gone any better.

“We had a chat about what was best, and I decided that I wanted to go home. Aziz told me that I was the first person, probably in the whole of Europe, to be able to do that. There was a bit of a buzz around it – you could really tell that the team cares about being the best at what they do and making sure that patients have the best recovery possible,” Sam says.

“To my knowledge, this is the first time that this has been done in Europe, which is just amazing,” says Mr Gulamhusein.

“Our goal as surgeons is always to ensure a safe and effective cancer operation, and if possible, carry it out in the least invasive way possible. Not long ago, this operation would have required a large incision, a hospital stay, and a long recovery. I’m looking forward to Sam getting back to the band and excited to see where they go in the future,” he adds.

Everyone is posting what they were up to in 2016, so we thought we'd get involved.Here's what was happening at The Chris...
23/01/2026

Everyone is posting what they were up to in 2016, so we thought we'd get involved.

Here's what was happening at The Christie ten years ago:

❤️ A 102-year-old woman had life-saving skin cancer surgery at The Christie
🎂 The Christie at Salford celebrated its 5th birthday
🏆 One of our nurses, Lorraine Turner, won a British Journal of Nursing award
🏥 We opened a new MRI suite at our Withington site
🏠 Christie nurses started treating certain patients at home
🏗️ The cyclotron for the proton beam therapy centre was built

Thousands of men who are newly diagnosed with prostate cancer will now benefit from taking abiraterone, a lifesaving hor...
21/01/2026

Thousands of men who are newly diagnosed with prostate cancer will now benefit from taking abiraterone, a lifesaving hormone therapy given as a tablet, after it was approved for use on the NHS.

Professor Noel Clarke, Consultant Urologist at The Christie, is co-principal investigator of STAMPEDE, the trial that initially proved the effectiveness of abiraterone as a novel therapy for treating men with high-risk locally advanced prostate cancer.

The study, which started testing multiple prostate cancer treatments in 2004, was the first ever to develop a new way of conducting medical trials, including those in cancer.

It was recognised by the National Institute for Health and Care Research in 2025 as one of the most impactful trials in medicine.

Professor Clarke said: “Our research showed that after just two years on the drug, the chances of the cancer coming back were halved and the risk of death was reduced by 40%, which has been life-changing for so many men and their families. This latest decision will see around 8,000 more men a year benefitting from the drug, which is fantastic."

Meet some of the people who provide religious and spiritual guidance and support at The Christie. 👋 Our team comprises C...
19/01/2026

Meet some of the people who provide religious and spiritual guidance and support at The Christie. 👋

Our team comprises Christian, Muslim, Jewish, and Buddhist chaplains, as well as representatives from a wider network of faiths and beliefs, including non-religious groups. They promise to listen in complete confidence and without judgement.

Our chapel, female Muslim prayer room, and multi-faith room can all be found in department 57 at our Withington site. The male Muslim prayer room is in Dept 41. The team can also visit patients on the ward.

Dr Hannah Harrison has been named as the first 'Sarah Harding Young Women's Breast Cancer Fellow'.She's been studying br...
14/01/2026

Dr Hannah Harrison has been named as the first 'Sarah Harding Young Women's Breast Cancer Fellow'.

She's been studying breast cancer for over 20 years, and this next phase of her work will focus on three key areas:

❓ Why some women don't respond to existing preventative treatments
🎯 Identifying new targets for prevention
🏥 Screening strategies for future treatments

Hannah is based at the Manchester Cancer Research Centre, which is a partnership between The Christie, The University of Manchester, and Cancer Research UK.

Funded by The Christie Charity, the fellowship is named after Sarah Harding, the Girls Aloud singer who died from breast cancer at 39.

“Our goal is simple: fewer breast cancer cases, fewer lives lost,” says Dr Harrison. “We need to understand why some women respond to current preventative drugs while others don’t, and to develop new strategies for those at risk.”

“By understanding resistance and response, we can give women the best chance to avoid breast cancer altogether, and every breakthrough we make brings us closer to saving lives. My passion is to create research models that reflect the complexity of human biology, so we can give patients hope for better treatments and outcomes.”

More👇

A new radiotherapy trial has just opened at The Christie. Researchers are looking at whether two de-escalated (lower dos...
12/01/2026

A new radiotherapy trial has just opened at The Christie.

Researchers are looking at whether two de-escalated (lower doses) of targeted radiotherapy are as effective as two regular doses at treating men with intermediate risk prostate cancer.

Professor Ananya Choudhury is the principal investigator at The Christie.

Ananya and the team hope that a lower dose could reduce effects such as urinary problems while still successfully treating the cancer.

Patients on the DESTINATION-2 trial are treated on the MR-linac – a machine that combines a conventional radiotherapy unit with an MRI scanner. As a result, the team can re-plan the treatment daily, adapting to changes in real-time.

“Radiotherapy technology and techniques have come on leaps and bounds in the last few years, and we as a radiotherapy research team are proud to have contributed to that,” comments Professor Cynthia Eccles, Consultant Research Radiographer and Head of Radiotherapy Research at The Christie.

“A lot of the research we’re doing now is about making treatment as ‘kind’ on the body as possible while still being effective. DESTINATION-2 is a great example of that.”

The trial is just one of the many radiotherapy trials taking place at The Christie. More than 460 patients took part in 52 trials in 2025 alone.

The Christie has been a centre for cancer care, treatment, and research for over 100 years. The hospital site has evolve...
10/01/2026

The Christie has been a centre for cancer care, treatment, and research for over 100 years.

The hospital site has evolved significantly over that time and is about to grow again, as we’ll be breaking ground on our new scanning centre next year.

The existing CT department was built in 1980 to treat around 20 patients a day. Today it sees more than 60.

Funded by donations to The Christie Charity, it'll will have better facilities and the most advanced equipment to support world-class cancer care, including a 4D CT scanner.

Here's a sneak peek of what the new scanning centre will look like. 👇

Address

550 Wilmslow Road
Manchester
M204BX

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+441614463000

Alerts

Be the first to know and let us send you an email when The Christie NHS Foundation Trust posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Christie NHS Foundation Trust:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

The Christie is one of Europe’s leading cancer centres, treating more than 44,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester and Cheshire, but as a national specialist around 26% patients are referred to us from other parts of the country. Our annual turnover is £173 million and we have 2,500 staff, 350 volunteers and 18,000 public members. NHS services We provide: • radiotherapy through one of the largest radiotherapy departments in the world, both on our main site in south Manchester and via The Christie radiotherapy centre in Oldham • chemotherapy in the largest chemotherapy unit in the UK and via 14 other hospitals • highly specialist surgery for complex and rare cancer • a wide range of support and diagnostic services Research & Education We are also an international leader in research, with world first breakthroughs for over 100 years. Our clinical trials unit is the largest early phase trials unit in the world, with around 200 trials ongoing at any one time. We are part of the Manchester Cancer Research Centre with The University of Manchester and Cancer Research UK and also one of seven partners in the Manchester Academic Health Science Research Centre. Cancer research in Manchester has been officially ranked the best in the UK. The Christie School of Oncology provides undergraduate education, clinical professional and medical education and is the first of its kind in the UK. Joint ventures We provide private patient services through The Christie Clinic, our joint venture with HCA International. These services help increase income for our NHS developments. Developments Our developments are breaking new ground and transforming treatment and care for cancer patients. These include a unique network of Christie radiotherapy centres in other parts of the area to deliver treatment closer to people’s homes and the development of our young oncology services in partnership with the Teenage Cancer Trust. History We have achieved world firsts since The Christie was established in 1901. It was named The Christie in recognition of the pioneering work of both Richard Copley Christie and his wife Mary Ellen Christie. At this time there were 30 beds and 463 patients a year. Charity Our charity is the second largest hospital charity in the country. Over 2,000 fundraisers and 20,000 supporters help bring in £15.9 million a year, which helps fund additional patient services and vital research. To find ‘The Christie charity’ on facebook please follow this link